TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was meas...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase [1-123](Homo sapiens (Human))
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the ph...More data for this Ligand-Target Pair
